Pharmaceutical giant Gilead reportedly sent a batch of an investigational coronavirus drug to China, without U.S. government approval. The company may have violated federal law by shipping the drug without the go-ahead from department of Health of Human Services officials. Axios reporter Caitlin Owens joins CBSN to discuss.
